Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)
China
· Delayed Price · Currency is CNY 19.04
+0.37 (1.98%)
Apr 29, 2026, 3:00 PM CST
SHA:605369 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,190 | 4,107 | 4,390 | 6,286 | 11,895 | 16,136 | Upgrade
|
| Market Cap Growth | -3.13% | -6.45% | -30.17% | -47.15% | -26.28% | 249.25% | Upgrade
|
| Enterprise Value | 3,746 | 3,712 | 3,978 | 5,789 | 11,150 | 15,414 | Upgrade
|
| Last Close Price | 19.04 | 18.66 | 19.76 | 27.57 | 51.42 | 68.89 | Upgrade
|
| PE Ratio | 74.74 | 79.73 | 25.58 | 57.61 | 36.48 | 51.89 | Upgrade
|
| Forward PE | 24.46 | 11.28 | 11.28 | 11.28 | 25.25 | - | Upgrade
|
| PS Ratio | 3.61 | 3.62 | 3.94 | 6.45 | 8.10 | 13.51 | Upgrade
|
| PB Ratio | 2.41 | 2.41 | 2.56 | 3.84 | 7.47 | 11.63 | Upgrade
|
| P/TBV Ratio | 2.99 | 3.00 | 3.25 | 4.71 | 7.86 | 12.35 | Upgrade
|
| P/FCF Ratio | 24.82 | 28.85 | 43.56 | 98.89 | 107.58 | 165.62 | Upgrade
|
| P/OCF Ratio | 14.72 | 16.17 | 20.87 | 33.91 | 42.07 | 43.26 | Upgrade
|
| EV/Sales Ratio | 3.23 | 3.27 | 3.57 | 5.94 | 7.59 | 12.91 | Upgrade
|
| EV/EBITDA Ratio | 16.37 | 17.39 | 16.82 | 29.92 | 30.56 | 43.11 | Upgrade
|
| EV/EBIT Ratio | 30.85 | 32.79 | 25.80 | 52.87 | 34.39 | 45.87 | Upgrade
|
| EV/FCF Ratio | 22.19 | 26.07 | 39.48 | 91.06 | 100.84 | 158.21 | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.10 | 0.03 | 0.02 | 0 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 1.05 | 0.76 | 0.21 | 0.18 | 0.00 | 0.00 | Upgrade
|
| Debt / FCF Ratio | 1.43 | 1.16 | 0.52 | 0.56 | 0.00 | 0.01 | Upgrade
|
| Net Debt / Equity Ratio | -0.27 | -0.27 | -0.23 | -0.25 | -0.47 | -0.58 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.04 | -2.16 | -1.66 | -2.13 | -2.06 | -2.26 | Upgrade
|
| Net Debt / FCF Ratio | -2.74 | -3.24 | -3.89 | -6.48 | -6.81 | -8.29 | Upgrade
|
| Asset Turnover | 0.55 | 0.56 | 0.58 | 0.52 | 0.83 | 0.78 | Upgrade
|
| Inventory Turnover | 6.53 | 5.80 | 5.58 | 5.37 | 7.59 | 7.36 | Upgrade
|
| Quick Ratio | 2.41 | 2.43 | 3.88 | 3.60 | 3.82 | 3.48 | Upgrade
|
| Current Ratio | 2.73 | 2.84 | 4.73 | 4.31 | 4.31 | 3.89 | Upgrade
|
| Return on Equity (ROE) | 3.21% | 3.00% | 10.22% | 6.75% | 21.88% | 23.96% | Upgrade
|
| Return on Assets (ROA) | 3.57% | 3.48% | 5.03% | 3.65% | 11.39% | 13.70% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.41% | 7.20% | 10.98% | 9.70% | 40.17% | 59.36% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.90% | 6.50% | 8.70% | 6.50% | 20.20% | 24.00% | Upgrade
|
| Earnings Yield | 1.34% | 1.25% | 3.91% | 1.74% | 2.74% | 1.93% | Upgrade
|
| FCF Yield | 4.03% | 3.47% | 2.30% | 1.01% | 0.93% | 0.60% | Upgrade
|
| Dividend Yield | 3.06% | - | 2.53% | 1.48% | 0.30% | 1.02% | Upgrade
|
| Payout Ratio | 118.31% | 127.52% | 47.33% | 82.56% | 47.67% | 46.30% | Upgrade
|
| Buyback Yield / Dilution | 1.14% | -1.59% | 0.43% | -0.82% | 0.20% | -23.76% | Upgrade
|
| Total Shareholder Return | 4.18% | -1.59% | 2.96% | 0.66% | 0.50% | -22.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.